Amyloid β induces NLRP3 inflammasome activation in retinal pigment epithelial cells via NADPH oxidase- and mitochondria-dependent ROS production

J Biochem Mol Toxicol. 2017 Jun;31(6). doi: 10.1002/jbt.21887. Epub 2016 Dec 22.

Abstract

Amyloid β (Aβ)-induced chronic inflammation is believed to be a key pathogenic process in early-stage age-related macular degeneration (AMD). Nucleotide oligomerization domain (NOD)-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome activation triggered by Aβ is responsible for retinal pigment epithelium (RPE) dysfunction in the onset of AMD; however, the detailed molecular mechanism remains unclear. In this study, we investigated the involvement of NADPH oxidase- and mitochondria-derived reactive oxygen species (ROS) in the process of Aβ1-40 -induced NLRP3 inflammasome activation in LPS-primed ARPE-19 cells. The results showed that Aβ1-40 could induce excessive ROS generation, MAPK/NF-κB signaling activation and subsequently NLRP3 inflammasome activation in LPS-primed ARPE-19 cells. Furthermore, the inductive effect of Aβ1-40 on NLRP3 inflammasome activation was mediated in a manner dependent on NADPH oxidase- and mitochondria-derived ROS. Our findings may provide a novel insight into the molecular mechanism by which Aβ contributes to the early-stage AMD.

Keywords: NLRP3 inflammasome; age-related macular degeneration; amyloid β; reactive oxygen species.

MeSH terms

  • Amyloid / metabolism
  • Amyloid beta-Peptides / metabolism*
  • Cell Line
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Inflammasomes / drug effects
  • Inflammasomes / immunology
  • Inflammasomes / metabolism*
  • Kinetics
  • Lipopolysaccharides / toxicity
  • MAP Kinase Signaling System / drug effects
  • Macular Degeneration / enzymology
  • Macular Degeneration / immunology
  • Macular Degeneration / metabolism*
  • Mitochondria / drug effects
  • Mitochondria / immunology
  • Mitochondria / metabolism
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism*
  • NF-kappa B / agonists
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / agonists*
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Oxidative Stress / drug effects
  • Peptide Fragments / metabolism*
  • Reactive Oxygen Species / agonists
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism*
  • Retinal Pigment Epithelium / drug effects
  • Retinal Pigment Epithelium / immunology
  • Retinal Pigment Epithelium / metabolism*
  • Sulfones / pharmacology

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Enzyme Inhibitors
  • Inflammasomes
  • Lipopolysaccharides
  • NF-kappa B
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • Peptide Fragments
  • Reactive Oxygen Species
  • Sulfones
  • amyloid beta-protein (1-40)
  • 4-(2-aminoethyl)benzenesulfonylfluoride
  • NADPH Oxidases